Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Cancer Imaging

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    September 2021
  1. XING P, Chen L, Yang Q, Song T, et al
    Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.
    Cancer Imaging. 2021;21:54.
    PubMed     Abstract available

    July 2021
  2. HE D, Wang X, Fu C, Wei X, et al
    MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
    Cancer Imaging. 2021;21:46.
    PubMed     Abstract available

    April 2021
  3. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
    Intra-patient comparison of physiologic (68)Ga-PSMA-11 and (18)F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay.
    Cancer Imaging. 2021;21:35.
    PubMed     Abstract available

    January 2021
  4. VENKATESAN AM, Mudairu-Dawodu E, Duran C, Stafford RJ, et al
    Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
    Cancer Imaging. 2021;21:3.
    PubMed     Abstract available

    October 2020
  5. PRICOLO P, Ancona E, Summers P, Abreu-Gomez J, et al
    Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
    Cancer Imaging. 2020;20:77.
    PubMed     Abstract available

  6. HIETIKKO R, Kilpelainen TP, Kenttamies A, Ronkainen J, et al
    Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.
    Cancer Imaging. 2020;20:72.
    PubMed     Abstract available

    August 2020
  7. DE LEIRIS N, Leenhardt J, Boussat B, Montemagno C, et al
    Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    Cancer Imaging. 2020;20:58.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.